• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

BIO Protocol and NuDAO Join Forces to Accelerate Decentralized Science Development

user avatar

by Giorgi Kostiuk

10 months ago


BIO Protocol and NuDAO have entered into a partnership aimed at strengthening the decentralized science ecosystem through strategic resource allocation and collaboration.

A Transformative Partnership

A recent press release announced NuDAO's strategic allocation of 6.9% of its treasury to BIO Protocol, highlighting a long-term collaboration to accelerate the decentralized science ecosystem. This partnership combines NuDAO's technological expertise in biotech and AI with BIO Protocol's established DeSci infrastructure.

This strategic partnership demonstrates our confidence in BIO Protocol’s vision and our shared commitment to advancing decentralized science.NuDAO

Key Elements of the Partnership

The partnership includes scientific and technical collaborations: * Joint Development: NuDAO and BIO Protocol will collaborate on significant scientific research initiatives, focusing on IP and NFT development. * Co-Incubation Projects: Both organizations will incubate promising research projects together, providing shared resources and expertise. * Governance: Both entities will actively participate in each other's governance frameworks, promoting collaboration and shared decision-making in DeSci development.

The Role of the CRISPR Token

A key component of the partnership is the integration of NuDAO's CRISPR token, which powers the research ecosystem. CRISPR will gain access to BIO Protocol’s research resources, driving innovation. CRISPR token holders will have the opportunity to participate in key decisions, influencing the future of decentralized science. The collaboration will enhance CRISPR’s position within the broader DeSci network, unlocking opportunities for growth and innovation.

The partnership aims to create a global decentralized research community enabling borderless collaboration. It supports the commercialization of biotech innovations, such as rare disease research and longevity research.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

India's VDA Review Focuses on Core Regulatory Challenges

chest

The ongoing review of India's virtual digital asset (VDA) framework focuses on core challenges like investor protection, market integrity, and taxation issues.

user avatarArif Mukhtar

Pumpfun Transfers Over $436 Million to Kraken Following Market Crash

chest

Pumpfun has transferred over $436 million in USDC to Kraken since mid-October, following a significant market crash.

user avatarDavid Robinson

Pumpfun's Monthly Revenue Declines Significantly After Market Crash

chest

Pumpfun's monthly revenue fell to $273 million in November, marking a 53% decline from September's $589 million, raising concerns about the platform's future in the memecoin market.

user avatarMaria Gutierrez

Enlivex Therapeutics Raises $212 Million for Crypto Investment

chest

Enlivex Therapeutics plans to raise $212 million through a private investment to invest in the Rain token, a decentralized prediction market.

user avatarAndrew Smith

Ifeoluwa Ogunbufunmi: From Lawyer to Tech Leader

chest

Ifeoluwa Ogunbufunmi, a former lawyer, has successfully transitioned into a tech leader and startup strategist.

user avatarJacob Williams

Cryptocurrencies Enhance Payment Options in Online Casinos

chest

Cryptocurrencies enhance payment options in online casinos.

user avatarSon Min-ho

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.